home / stock / rani / rani quote
Last: | $3.76 |
---|---|
Change Percent: | 0.0% |
Open: | $3.85 |
Close: | $3.76 |
High: | $3.95 |
Low: | $3.65 |
Volume: | 14,344 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3.76 | $3.85 | $3.76 | $3.95 | $3.65 | 14,344 | 07-04-2024 |
$3.76 | $3.85 | $3.76 | $3.95 | $3.65 | 14,344 | 07-03-2024 |
$3.87 | $3.83 | $3.87 | $4 | $3.7894 | 16,055 | 07-02-2024 |
$3.82 | $3.82 | $3.82 | $3.9 | $3.7166 | 19,291 | 07-01-2024 |
$3.8 | $3.88 | $3.8 | $3.96 | $3.52 | 70,828 | 06-28-2024 |
$3.94 | $3.93 | $3.94 | $4.1 | $3.72 | 38,210 | 06-27-2024 |
$3.89 | $3.84 | $3.89 | $4.2 | $3.82 | 27,204 | 06-26-2024 |
$3.74 | $4.11 | $3.74 | $4.1992 | $3.74 | 69,393 | 06-25-2024 |
$4.11 | $4.25 | $4.11 | $4.37 | $4 | 48,001 | 06-24-2024 |
$4.15 | $4.07 | $4.15 | $4.25 | $4 | 134,100 | 06-21-2024 |
$4 | $3.9 | $4 | $4.2052 | $3.9 | 47,784 | 06-20-2024 |
$3.89 | $3.81 | $3.89 | $4.05 | $3.81 | 44,579 | 06-19-2024 |
$3.89 | $3.81 | $3.89 | $4.05 | $3.81 | 44,579 | 06-18-2024 |
$3.81 | $4.06 | $3.81 | $4.205 | $3.81 | 55,739 | 06-17-2024 |
$4.03 | $4.06 | $4.03 | $4.45 | $4.03 | 110,381 | 06-14-2024 |
$4.08 | $4.09 | $4.08 | $4.21 | $4.01 | 25,995 | 06-13-2024 |
$4 | $4 | $4 | $4.361 | $3.94 | 55,850 | 06-12-2024 |
$4.01 | $4.16 | $4.01 | $4.44 | $4 | 39,741 | 06-11-2024 |
$4.15 | $4.49 | $4.15 | $4.6319 | $4.07 | 100,594 | 06-10-2024 |
$4.39 | $4.54 | $4.39 | $4.745 | $4.3 | 31,140 | 06-07-2024 |
News, Short Squeeze, Breakout and More Instantly...
Rani Therapeutics Holdings Inc. Company Name:
RANI Stock Symbol:
NASDAQ Market:
Rani Therapeutics Holdings Inc. Website:
~ New RT-114 obesity program combines ProGen’s FC Fusion protein conjugated GLP-1/GLP-2 dual agonist, PG-102, with the RaniPill® capsule designed to provide a differentiated oral delivery mechanism with bioavailability comparable to subcutaneous injection ~ ~ Rani and Pr...
2024-05-16 19:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SAN JOSE, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that the Company will parti...